Trauma News and Research

RSS

Lung protective strategy can increase the number of lungs available for transplant

Simple changes to how ventilators are used could almost double the number of lungs available for transplants, according to new international research involving a doctor at St. Michael's Hospital.

15 Dec 2010

Marin announces new joint venture with Mt. Tam Spine Center and UCSF Neurosurgery

Marin General Hospital has announced a new joint venture that provides a single point of access in Marin for world-class, comprehensive multidisciplinary and cross-disciplinary treatment and management of spine and brain disorders and disease.

15 Dec 2010

DARA's KRN5500 reduces allodynia in Phase 2a study for neuropathic pain in cancer patients

DARA BioSciences, Inc. announced today additional positive results from its successfully completed KRN5500 Phase 2a Clinical Study for treatment of neuropathic pain in patients with cancer. Statistically significant primary endpoint results were released earlier.

15 Dec 2010

African American patients less likely to receive medications for parkinsonian symptoms

African American patients and those with lower socioeconomic status have more advanced disease and greater disability when they seek treatment from Parkinson's disease specialists, according to a study from the University of Maryland School of Medicine.

14 Dec 2010

UCSF physicians evlaute devices that could reduce hair loss in breast cancer patients undergoing chemotherapy

UCSF physicians are combating a devastating side effect of chemotherapy with an innovative new program -- "Hair to Stay" -- to evaluate devices that could reduce scalp hair loss in breast cancer patients.

14 Dec 2010

Zimmer's Trabecular Metal Modular Cup awarded 20% reimbursement premium in Japan

Zimmer Holdings, Inc., a global leader in musculoskeletal care, announced today that the Trabecular Metal Modular Cup has received the distinction of being awarded the highest reimbursement premium percentage granted to-date for an orthopaedic product in Japan.

13 Dec 2010

New DNA-based testing technology for tuberculosis treatment

The driving force behind the rapid tuberculosis test that received World Health Organization endorsement this week is Dr. David Alland, chief of the Division of Infectious Disease at UMDNJ-New Jersey Medical School.

13 Dec 2010

New study says boxers are at substantial risk for acute injuries to head, heart, and skeleton

Boxers are at substantial risk for acute injuries to the head, heart, and skeleton. Subacute consequences after being knocked out include persistent symptoms such as headaches, impaired hearing, nausea, unstable gait, and forgetfulness.

13 Dec 2010

Repeated cerebral trauma in boxing career may result in boxer's dementia

Up to 20% of professional boxers develop neuropsychiatric sequelae. But which acute complications and which late sequelae can boxers expect throughout the course of their career? These are the questions studied by Hans Förstl from the Technical University Munich and his co-authors in the current issue of Deutsches Ärzteblatt International (Dtsch Arztebl Int 2010; 107[47]: 835-9).

10 Dec 2010

Using buprenorphine to treat opioid-dependent pregnant women may result in healthier babies

Using buprenorphine instead of methadone — the current standard of care — to treat opioid-dependent pregnant women may result in healthier babies, suggests new findings from an international team led by Johns Hopkins researchers and published in the Dec. 9 issue of the New England Journal of Medicine.

10 Dec 2010

Report shows hospitalizations for eating disorders in children increase at an alarming rate

A recent report published by the American Academy of Pediatrics shows hospitalizations for eating disorders in children under 12 increased 119 percent between 1999 and 2006. "This is an alarming trend because small children develop their foundation of self worth and body worth in their early years (birth to five years old)," said Dr. Kimberly Dennis, medical director at Timberline Knolls Residential Treatment Center.

10 Dec 2010

Acorda initiates enrollment in GGF2 Phase 1 clinical trial in patients with heart failure

Acorda Therapeutics, Inc. today announced that the first patient has been enrolled in the first clinical trial of Glial Growth Factor 2 (GGF2). Acorda is collaborating with the Vanderbilt University Heart and Vascular Institute to conduct this Phase 1 single-dose trial in patients with heart failure.

9 Dec 2010

Ellipse's PRECICE Limb Lengthening device receives CE-Mark approval

Ellipse Technologies, Inc. announced today that it has received CE-Mark approval of the Company's PRECICETM Limb Lengthening device. Limb Lengthening procedures are used to treat a number of medical conditions, including shortened legs due to congenital abnormalities, major fractures of one of the legs and shortened leg bones due to other medical diseases, such as cancer.

9 Dec 2010

Trauma surgeon co-authors call to action to establish pediatric trauma research network

Jeffrey S. Upperman, MD, director of the Trauma Program at Children's Hospital Los Angeles, has co-authored a call to action for filling a significant gap in pediatric public health care and seeks federal oversight to establish the framework for a pediatric applied trauma research network (PATRN). This call to action was published simultaneously in the Journal of Pediatric Surgery and the Journal of Trauma.

9 Dec 2010

Systagenix launches new innovative website

Following the highly successful global launch of the new Corporate Identity, Systagenix has today unveiled its new innovative website - www.systagenix.com.

9 Dec 2010

New objective criteria for evaluating hemostatic efficacy in treatment of VWD

Octapharma USA researchers presented new stringent, objective criteria used in the evaluation of hemostatic efficacy in the treatment of von Willebrand disease and reported on their application of these criteria in clinical trials during the recently completed National Hemophilia Foundation Annual Meeting.

9 Dec 2010

Myriad to acquire technology for diagnosis, prognosis of malignant melanoma

Myriad Genetics, Inc. today announced that it has signed an agreement to acquire proprietary technology for the diagnosis and prognosis of malignant melanoma using highly validated genetic markers from Melanoma Diagnostics, Inc. of Altadena, California. Under the agreement, Myriad has the right to commercialize all tests derived from the technology on a worldwide basis in exchange for upfront fees and contingent payments based upon the commercial success of the products.

8 Dec 2010

Swissmedic authorizes Phase I/II clinical trial of human neural stem cells for chronic spinal cord injury

A therapy developed by Aileen Anderson and Brian Cummings of UC Irvine's Sue and Bill Gross Stem Cell Research Center in collaboration with researchers at StemCells Inc. will be the basis of the world's first clinical trial using human neural stem cells to treat spinal cord injury.

8 Dec 2010

Injury prevention for young volleyball athletes

When volleyball was invented 115 years ago in Holyoke, Mass., it was meant to be less rough than basketball, another emerging indoor sport that started four years earlier at a nearby YMCA.

7 Dec 2010

Lutheran Medical Center implements Medsphere's OpenVista EHR solution

Lutheran Medical Center (LMC) and Medsphere Systems Corporation today announced the successful implementation of Medsphere's OpenVista® electronic health record (EHR) solution throughout the hospital. The full service 476-bed teaching hospital is now on track to achieve meaningful use and qualify for millions of dollars made available by the American Recovery and Reinvestment Act of 2009.

7 Dec 2010

Trauma News and Research

Lung protective strategy can increase the number of lungs available for transplant

Marin announces new joint venture with Mt. Tam Spine Center and UCSF Neurosurgery

DARA's KRN5500 reduces allodynia in Phase 2a study for neuropathic pain in cancer patients

African American patients less likely to receive medications for parkinsonian symptoms

UCSF physicians evlaute devices that could reduce hair loss in breast cancer patients undergoing chemotherapy

Zimmer's Trabecular Metal Modular Cup awarded 20% reimbursement premium in Japan

New DNA-based testing technology for tuberculosis treatment

New study says boxers are at substantial risk for acute injuries to head, heart, and skeleton

Repeated cerebral trauma in boxing career may result in boxer's dementia

Using buprenorphine to treat opioid-dependent pregnant women may result in healthier babies

Report shows hospitalizations for eating disorders in children increase at an alarming rate

Acorda initiates enrollment in GGF2 Phase 1 clinical trial in patients with heart failure

Ellipse's PRECICE Limb Lengthening device receives CE-Mark approval

Trauma surgeon co-authors call to action to establish pediatric trauma research network

Systagenix launches new innovative website

New objective criteria for evaluating hemostatic efficacy in treatment of VWD

Myriad to acquire technology for diagnosis, prognosis of malignant melanoma

Swissmedic authorizes Phase I/II clinical trial of human neural stem cells for chronic spinal cord injury

Injury prevention for young volleyball athletes

Lutheran Medical Center implements Medsphere's OpenVista EHR solution

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News